Status: Not yet recruiting
Multicenter Prospective Non-randomized Controlled Study of ALA-PDT for LSIL With HPV16/18 Infection
This multicenter, prospective trial assesses ALA-PDT versus observation for efficacy and safety in treating cervical LSIL with HPV16/18 infection.
Participants needed: 225
Trial details
Age: 20-60Biological sex: FemaleType: InterventionalSponsor: Second Affiliated Hospital, School of Medicine, Zhejiang UniversityUpdated: Dec 29, 2025Locations: 5
Eligibility criteria
Female, 20-60 years, understands study procedures and consents to participate; [+3]
Cytology showing ASC-H, HSIL, AGC, or AIS; or evidence of malignant cells on cyt... [+9]